Akso Health Group · NASDAQ:AHG

Akso Health Group financial statements

Akso Health Group's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue13.8M14.8M2.41M13.2M6.00M1.75M6.91M3.70M107.3M22.9M
Cost of revenue13.8M15.1M2.29M11.9M5.39M544.6K1.03M7.40M8.50M5.15M
Gross profit-11.3K-281.5K122.1K1.27M605.1K1.75M6.91M53.9M107.3M22.9M
Research and development4421.2K421.2K441.4K117.9K02.82M1.57M
Selling, general and administrative3.99M3.64M8.59M15.5M15.4M2.03M20.8M16.5M7.64M2.65M
Operating income-20.7M-166.3M-8.64M-14.3M-3.26M-4.24M-48.1M-7.19M75.9M9.91M
Depreciation and amortization2.37M2.15M018.4K18.4K15.2K120.5K17.2K174.4K92.2K
EBITDA-18.3M-164.2M-8.64M-14.2M-3.24M-4.23M-48.0M-7.17M76.0M10.0M
Interest expense0804.1K804.1K2.15M2.50M00
Income before tax-20.7M-166.3M-9.09M-13.1M-4.01M-4.29M-46.9M-6.81M76.5M10.1M
Income tax-1.99M-30.8M25.0K17.5K92.8K483.0K490.0K807.7K11.0M1.52M
Net income-18.7M-135.0M-9.46M-1.36M-16.9M-34.8M-71.2M5.53M65.5M8.57M
Earnings per share, basic0.010.160.07-0.02-0.28-0.71-1.460.111.460.20
Earnings per share, diluted0.010.160.07-0.02-0.28-0.71-1.460.101.370.20

Balance sheet

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents170.6K176.2M85.2M7.92M18.4M15.1M6.67M57.4M132.6M19.2M
Receivables1.28M954.2K56.3M7.70M20.0M14.4M36.3M140.6K02.17M
Inventory200.1K190.2K191.2K1.69M7.80M-14.4M-39.0B-2.08M128.5M
Current assets189.5M196.1M142.0M20.5M62.8M30.1M52.0M97.7M163.1M27.6M
Property, plant and equipment12.0K16.1K55.4K66.9K92.8K1.25M767.1K427.9K
Goodwill010.8M0
Total assets189.6M215.0M142.0M20.5M62.8M50.7M80.5M173.3M163.9M28.4M
Accounts payable-2.00M-9.69M
Current liabilities8.71M13.8M3.59M11.6M50.5M14.4M12.4M26.6M23.8M4.88M
Long-term debt20.0M20.0M
Total debt375.7K81.7K2.00M9.69M10.0M20.8M20.0M
Total liabilities8.71M15.8M3.59M11.6M50.5M14.4M32.4M46.8M23.8M4.88M
Shareholders' equity180.9M199.1M138.4M8.73M12.3M17.3M48.1M126.5M140.0M23.5M
Shares outstanding722.7M1.66B437.2M68.6M68.6M48.9M48.8M49.2M48.0M42.9M

Cash flow

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations-12.8M1.18M1.35M-3.25M-8.63M10.1M-58.3M-1.73M87.7M8.19M
Capital spending-1.64K-154.5K0-4.86K-4.86K-4.86K-200.4K-7.59K-456.0K-287.8K
Free cash flow-12.8M1.02M1.35M-3.25M-8.63M10.1M-58.5M-1.74M87.3M7.90M
Cash from investing-163.5M-105.9M-54.7M18.5M-20.0M-66212.8M-68.1M-27.6M-287.8K
Cash from financing350.0K195.9M131.7M-27.5M34.8M-9.04M-1.55M-29.4K47.5M4.29M
Dividends paid00-19.5M-19.5M
Share buybacks00-2.67M-1.32M
Change in cash-176.1M90.0M77.0M-12.7M6.80M4.20M-46.4M-75.3M113.4M11.4M